Header Logo

Connection

FIDA BACHA to Adolescent

Back to Details
This is a "connection" page, showing publications FIDA BACHA has written about Adolescent.
FIDA BACHA
Connection Strength
1.793
Adolescent
  1. Prediction models of basal energy expenditure in children and adolescents across the BMI spectrum based on room calorimetry: a cross-sectional cohort study. Am J Clin Nutr. 2025 Feb; 121(2):284-292.
    View in: PubMed
    Score: 0.066
  2. Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024 Dec 01; 47(12):2038-2049.
    View in: PubMed
    Score: 0.066
  3. Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
    View in: PubMed
    Score: 0.063
  4. Prognostic factors in resolution of nonalcoholic fatty liver disease post bariatric surgery in adolescents. Surg Obes Relat Dis. 2024 04; 20(4):367-375.
    View in: PubMed
    Score: 0.062
  5. Hyperglycemia: A determinant of cardiac autonomic dysfunction in youth with obesity across the spectrum of glycemic regulation. Pediatr Obes. 2023 10; 18(10):e13063.
    View in: PubMed
    Score: 0.060
  6. Candidate biomarkers as predictors of future kidney disease and cardiovascular dysfunction in adolescents with type 2 diabetes. Diabetes Res Clin Pract. 2023 May; 199:110671.
    View in: PubMed
    Score: 0.059
  7. Adiposity, Insulin Resistance, Cardiorespiratory Fitness, and Bone Health in Hispanic Children. J Clin Endocrinol Metab. 2022 08 18; 107(9):e3797-e3804.
    View in: PubMed
    Score: 0.057
  8. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight. 2021 02 22; 6(4).
    View in: PubMed
    Score: 0.051
  9. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial. Pediatr Diabetes. 2019 11; 20(7):871-879.
    View in: PubMed
    Score: 0.046
  10. FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.
    View in: PubMed
    Score: 0.046
  11. Free Vitamin D: Relationship to Insulin Sensitivity and Vascular Health in Youth. J Pediatr. 2019 09; 212:28-34.e2.
    View in: PubMed
    Score: 0.045
  12. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Horm Res Paediatr. 2018; 89(1):47-55.
    View in: PubMed
    Score: 0.041
  13. Race or vitamin D: A determinant of intima media thickness in obese adolescents? Pediatr Diabetes. 2017 Nov; 18(7):619-621.
    View in: PubMed
    Score: 0.038
  14. Endothelial Function in Youth: A Biomarker Modulated by Adiposity-Related Insulin Resistance. J Pediatr. 2016 Nov; 178:171-177.
    View in: PubMed
    Score: 0.037
  15. Relationship of Cardiac Structure and Function to Cardiorespiratory Fitness and Lean Body Mass in Adolescents and Young Adults with Type 2 Diabetes. J Pediatr. 2016 10; 177:159-166.e1.
    View in: PubMed
    Score: 0.037
  16. Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes. Curr Diab Rep. 2016 07; 16(7):62.
    View in: PubMed
    Score: 0.037
  17. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes. Pediatr Diabetes. 2016 12; 17(8):545-558.
    View in: PubMed
    Score: 0.035
  18. Urine Albumin-to-Creatinine Ratio: A Marker of Early Endothelial Dysfunction in Youth. J Clin Endocrinol Metab. 2015 Sep; 100(9):3393-9.
    View in: PubMed
    Score: 0.035
  19. Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood. Pediatr Diabetes. 2015 Sep; 16(6):419-26.
    View in: PubMed
    Score: 0.034
  20. Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants? Diabetes Care. 2014 Sep; 37(9):2632-9.
    View in: PubMed
    Score: 0.033
  21. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J Pediatr. 2013 May; 162(5):924-9.
    View in: PubMed
    Score: 0.029
  22. Progressive deterioration of ?-cell function in?obese youth with type 2 diabetes. Pediatr Diabetes. 2013 Mar; 14(2):106-11.
    View in: PubMed
    Score: 0.028
  23. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012 Nov; 61(11):2787-95.
    View in: PubMed
    Score: 0.028
  24. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012 Aug; 13(5):376-83.
    View in: PubMed
    Score: 0.027
  25. Type 2 diabetes in youth: are there racial differences in ?-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes. 2012 May; 13(3):259-65.
    View in: PubMed
    Score: 0.027
  26. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010 Oct; 33(10):2225-31.
    View in: PubMed
    Score: 0.024
  27. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care. 2009 Jan; 32(1):100-5.
    View in: PubMed
    Score: 0.022
  28. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care. 2006 Jul; 29(7):1599-604.
    View in: PubMed
    Score: 0.018
  29. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2017 08; 12(4):337-345.
    View in: PubMed
    Score: 0.018
  30. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes. Diabetes Care. 2015 Dec; 38(12):2285-92.
    View in: PubMed
    Score: 0.018
  31. Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial. Obesity (Silver Spring). 2015 Jul; 23(7):1357-61.
    View in: PubMed
    Score: 0.017
  32. Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
    View in: PubMed
    Score: 0.017
  33. Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty. J Clin Psychopharmacol. 2024 Nov-Dec; 44(6):538-544.
    View in: PubMed
    Score: 0.016
  34. The association of self-reported sleep and circadian measures with glycemic control and diabetes complications among young adults with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2024 06 01; 326(6):H1386-H1395.
    View in: PubMed
    Score: 0.016
  35. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care. 2004 Feb; 27(2):547-52.
    View in: PubMed
    Score: 0.016
  36. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obes Metab. 2023 11; 25(11):3420-3423.
    View in: PubMed
    Score: 0.015
  37. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003 Jun; 88(6):2534-40.
    View in: PubMed
    Score: 0.015
  38. Relationship between Arterial Stiffness and Subsequent Cardiac Structure and Function in Young Adults with Youth-Onset Type 2 Diabetes: Results from the TODAY Study. J Am Soc Echocardiogr. 2022 06; 35(6):620-628.e4.
    View in: PubMed
    Score: 0.014
  39. Metabolic inflexibility in youth with obesity: Is it a feature of obesity or distinctive of youth who are metabolically unhealthy? Clin Obes. 2022 Apr; 12(2):e12501.
    View in: PubMed
    Score: 0.013
  40. Longitudinal changes in vascular stiffness and heart rate variability among young adults with youth-onset type 2 diabetes: results from the follow-up observational treatment options for type 2 diabetes in adolescents and youth (TODAY) study. Acta Diabetol. 2022 Feb; 59(2):197-205.
    View in: PubMed
    Score: 0.013
  41. Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
    View in: PubMed
    Score: 0.013
  42. Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021 07 29; 385(5):416-426.
    View in: PubMed
    Score: 0.013
  43. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.013
  44. Pasteurella multocida pneumonia in an adolescent with Duchenne's muscular dystrophy following exposure to his helper dog. Clin Pediatr (Phila). 2001 Mar; 40(3):159-61.
    View in: PubMed
    Score: 0.013
  45. Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study. Pediatr Diabetes. 2020 09; 21(6):923-931.
    View in: PubMed
    Score: 0.012
  46. ?-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak. Pediatr Diabetes. 2020 02; 21(1):18-27.
    View in: PubMed
    Score: 0.012
  47. Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 11; 42(11):2143-2150.
    View in: PubMed
    Score: 0.012
  48. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care. 2019 01; 42(1):164-172.
    View in: PubMed
    Score: 0.011
  49. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
    View in: PubMed
    Score: 0.011
  50. Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatr Diabetes. 2018 12; 19(8):1379-1384.
    View in: PubMed
    Score: 0.011
  51. Response to Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024. Diabetes Care. 2018 07; 41(7):e125-e126.
    View in: PubMed
    Score: 0.011
  52. Prevalence of arterial stiffness in adolescents with type 2 diabetes in the TODAY cohort: Relationships to glycemic control and other risk factors. J Diabetes Complications. 2018 Aug; 32(8):740-745.
    View in: PubMed
    Score: 0.011
  53. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.010
  54. Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes. J Pediatr. 2018 05; 196:208-216.e2.
    View in: PubMed
    Score: 0.010
  55. Diagnostic Evaluation, Comorbidity Screening, and Treatment of Polycystic Ovary Syndrome in Adolescents in 3 Specialty Clinics. J Pediatr Adolesc Gynecol. 2018 Aug; 31(4):367-371.
    View in: PubMed
    Score: 0.010
  56. Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr. 2018 01; 192:86-92.e5.
    View in: PubMed
    Score: 0.010
  57. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical?Trial. Am J Kidney Dis. 2018 01; 71(1):65-74.
    View in: PubMed
    Score: 0.010
  58. Increased Lipolysis, Diminished Adipose Tissue Insulin Sensitivity, and Impaired ?-Cell Function Relative to Adipose Tissue Insulin Sensitivity in Obese Youth With Impaired Glucose Tolerance. Diabetes. 2017 12; 66(12):3085-3090.
    View in: PubMed
    Score: 0.010
  59. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off? Pediatr Diabetes. 2018 03; 19(2):205-211.
    View in: PubMed
    Score: 0.010
  60. Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care. 2017 Jan; 40(1):85-93.
    View in: PubMed
    Score: 0.009
  61. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes Care. 2016 Aug; 39(8):1431-9.
    View in: PubMed
    Score: 0.009
  62. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 05; 18(3):222-229.
    View in: PubMed
    Score: 0.009
  63. Differences in ?-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role? Pediatr Diabetes. 2017 03; 18(2):143-151.
    View in: PubMed
    Score: 0.009
  64. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2015 Dec 01; 314(21):2241-50.
    View in: PubMed
    Score: 0.009
  65. Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience. Diabetes Care. 2016 Jan; 39(1):122-9.
    View in: PubMed
    Score: 0.009
  66. Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Pediatr Diabetes. 2016 12; 17(8):584-591.
    View in: PubMed
    Score: 0.009
  67. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.009
  68. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes. 2016 09; 17(6):458-65.
    View in: PubMed
    Score: 0.009
  69. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr. 2015 Sep; 167(3):627-32.e1-4.
    View in: PubMed
    Score: 0.009
  70. Pre-diabetes in overweight youth and early atherogenic risk. Metabolism. 2014 Dec; 63(12):1528-35.
    View in: PubMed
    Score: 0.008
  71. ?-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes. 2014 Nov; 63(11):3846-55.
    View in: PubMed
    Score: 0.008
  72. Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial. Pediatr Diabetes. 2015 Feb; 16(1):39-47.
    View in: PubMed
    Score: 0.008
  73. 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care. 2013 Jul; 36(7):2048-53.
    View in: PubMed
    Score: 0.007
  74. Measuring ?-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice? Diabetes Care. 2013 Jun; 36(6):1607-12.
    View in: PubMed
    Score: 0.007
  75. Metabolomic profiling of amino acids and ?-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012 Nov; 97(11):E2119-24.
    View in: PubMed
    Score: 0.007
  76. HbA(1c) diagnostic categories and ?-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care. 2012 Dec; 35(12):2559-63.
    View in: PubMed
    Score: 0.007
  77. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr. 2012 Jul; 161(1):51-7.
    View in: PubMed
    Score: 0.007
  78. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012 Mar; 35(3):605-11.
    View in: PubMed
    Score: 0.007
  79. Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr. 2011; 76(6):379-85.
    View in: PubMed
    Score: 0.007
  80. Declining ?-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care. 2011 Sep; 34(9):2033-40.
    View in: PubMed
    Score: 0.007
  81. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011 Jul; 96(7):2136-45.
    View in: PubMed
    Score: 0.006
  82. One-hour plasma glucose concentration during the OGTT: what does it tell about ?-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes. 2011 Sep; 12(6):572-9.
    View in: PubMed
    Score: 0.006
  83. ?-cell autoimmunity in overweight non-diabetic youth: any implications? Pediatr Diabetes. 2011 May; 12(3 Pt 2):207-11.
    View in: PubMed
    Score: 0.006
  84. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care. 2010 Mar; 33(3):632-8.
    View in: PubMed
    Score: 0.006
  85. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function? Diabetes Care. 2008 Jul; 31(7):1445-7.
    View in: PubMed
    Score: 0.005
  86. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008 Feb; 152(2):177-84.
    View in: PubMed
    Score: 0.005
  87. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. 2007 Aug; 30(8):2091-7.
    View in: PubMed
    Score: 0.005
  88. Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr. 2006 Dec; 149(6):809-16.
    View in: PubMed
    Score: 0.005
  89. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes. 2006 Oct; 7(5):260-6.
    View in: PubMed
    Score: 0.005
  90. Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity (Silver Spring). 2006 Sep; 14(9):1579-85.
    View in: PubMed
    Score: 0.005
  91. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006 Feb; 148(2):188-94.
    View in: PubMed
    Score: 0.004
  92. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006 Jan; 29(1):51-6.
    View in: PubMed
    Score: 0.004
  93. Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am. 2005 Dec; 52(6):1579-609.
    View in: PubMed
    Score: 0.004
  94. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care. 2005 Mar; 28(3):638-44.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.